What are the anti-angiogenic drugs for lung cancer?

What are the anti-angiogenic drugs for lung cancer?

Anti-vascular drugs for lung cancer mainly include bevacizumab injection, recombinant human endostatin injection, anlotinib hydrochloride capsules, etc.

1. Bevacizumab injection:

This drug is a targeted drug suitable for various tumors. By inhibiting the biological activity of human vascular endothelial growth factor, it can reduce the generation of tumor microvessels and inhibit the progression of metastatic lesions. It can be used clinically to treat metastatic colorectal cancer, non-small cell lung cancer and other diseases.

2. Recombinant human endostatin injection:

This drug can play an anti-cancer role and is mainly used to treat non-small cell lung cancer, inhibit the migration of vascular endothelial cells, inhibit the generation of new tumor blood vessels, block the nutrient supply of tumor cells, and achieve the purpose of inhibiting tumor proliferation or metastasis.

3. Anlotinib Hydrochloride Capsules:

This drug is mainly used to treat lung cancer, sarcoma, renal cell carcinoma, thyroid cancer and other diseases, and achieves anti-tumor purposes through vascular endothelial growth factor.